Tom van Meerten

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 24

Top Topics

Aortic Dissection

Hodgkin Lymphoma

Respiratory Failure

Top Venues

JCO oncology practice

Blood cancer journal

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kylie Keijzer, Janneke W de Boer, Jaap A van Doesum, Walter Noordzij, Gerwin A Huls, Lisanne V van Dijk, Tom van Meerten, Anne G H Niezink
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma. Blood cancer journal 14 (1) (2024)
Kylie Keijzer, Janneke W de Boer, Jaap A van Doesum, Walter Noordzij, Gerwin A Huls, Lisanne V van Dijk, Tom van Meerten, Anne G H Niezink
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma. Blood cancer journal 14 (1) (2024)
Kylie Keijzer, Janneke W de Boer, Jaap A van Doesum, Walter Noordzij, Gerwin A Huls, Lisanne V van Dijk, Tom van Meerten, Anne G H Niezink
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma. Blood cancer journal 14 (1) (2024)
Jason R Westin, Olalekan O Oluwole, Marie José Kersten, David B Miklos, Miguel-Angel Perales, Armin Ghobadi, Aaron P Rapoport, Anna Sureda, Caron A Jacobson, Umar Farooq, Tom van Meerten, Matthew Ulrickson, Mahmoud Elsawy, Lori A Leslie, Sridhar Chaganti, Michael J Dickinson, Kathleen Dorritie, Patrick M Reagan, Joseph McGuirk, Kevin W Song, Peter A Riedell, Monique C Minnema, Yin Yang, Saran Vardhanabhuti, Simone Filosto, Paul Cheng, Shilpa A Shahani, Marco Schupp, Christina To, Frederick L Locke, null null
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma. The New England journal of medicine (2023)
Janneke W de Boer, Kylie Keijzer, Elise R A Pennings, Jaap A van Doesum, Anne M Spanjaart, Margot Jak, Pim G N J Mutsaers, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Lisanne V van Dijk, Marie José Kersten, Anne G H Niezink, Tom van Meerten, null null
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities. Cancers 15 (22) (2023)
Anne M Spanjaart, Elise R A Pennings, Pim G N J Mutsaers, Suzanne van Dorp, Margot Jak, Jaap A van Doesum, Janneke W de Boer, Anne G H Niezink, Milan Kos, Joost S P Vermaat, Aniko Sijs-Szabo, Marjolein W M van der Poel, Inger S Nijhof, Maria T Kuipers, Martine E D Chamuleau, Pieternella J Lugtenburg, Jeanette K Doorduijn, Yasmina I M Serroukh, Monique C Minnema, Tom van Meerten, Marie José Kersten, null null
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands. Cancers 15 (17) (2023)
Jason R Westin, Frederick L Locke, Michael J Dickinson, Armin Ghobadi, Mahmoud Elsawy, Tom van Meerten, David Bernard Miklos, Matthew L Ulrickson, Miguel-Ángel Perales, Umar Farooq, Luciano Wannesson, Lori A Leslie, Marie José Kersten, Caron A Jacobson, John M Pagel, Gerald Georg Wulf, Patrick B Johnston, Aaron P Rapoport, Linqiu Du, Saran Vardhanabhuti, Simone Filosto, Jina Shah, Julia Thornton Snider, Paul Cheng, Christina To, Olalekan O Oluwole, Anna Sureda
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jimena Álvarez Freile, Natasha Ustyanovska, Macarena González Corrales, Harm Jan Lourens, Gerwin Huls, Tom van Meerten, Ewa Cendrowicz, Edwin Bremer
CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma. Biomedicines 10 (5) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Myra Langendonk, Mathilde R W de Jong, Nienke Smit, Jonas Seiler, Bart Reitsma, Emanuele Ammatuna, Andor W J M Glaudemans, Anke van den Berg, Gerwin A Huls, Lydia Visser, Tom van Meerten
Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma. Blood cancer journal 12 (3) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Myra Langendonk, Nienke A M Smit, Wouter Plattel, Arjan Diepstra, Tom van Meerten, Lidia Visser
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma. International journal of molecular sciences 23 (22) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice (2022)
Yuan He, Martijn R Vlaming, Tom van Meerten, Edwin Bremer
The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity. Cancers 14 (2) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Diana Al-Sarayfi, Frederik O Meeuwes, Müjde Durmaz, Djamila E Issa, Rolf E Brouwer, Aart Beeker, Anna van Rhenen, Pim G N J Mutsaers, Lara H Böhmer, Marjolein W M van der Poel, Liane Te Boome, Tom van Meerten, Martine E D Chamuleau, Josée M Zijlstra, Mirian Brink, Marcel Nijland
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma. Blood cancer journal 12 (9) (2022)
Marieke Tienstra, Janneke W de Boer, Jaap A van Doesum, Tom van Meerten, Peter Ruben van Dijk
High frequency of hyperglycaemia observed during CAR T-cell treatment. Diabetic medicine : a journal of the British Diabetic Association (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Frederick L Locke, David B Miklos, Caron A Jacobson, Miguel-Angel Perales, Marie-José Kersten, Olalekan O Oluwole, Armin Ghobadi, Aaron P Rapoport, Joseph McGuirk, John M Pagel, Javier Muñoz, Umar Farooq, Tom van Meerten, Patrick M Reagan, Anna Sureda, Ian W Flinn, Peter Vandenberghe, Kevin W Song, Michael Dickinson, Monique C Minnema, Peter A Riedell, Lori A Leslie, Sridhar Chaganti, Yin Yang, Simone Filosto, Jina Shah, Marco Schupp, Christina To, Paul Cheng, Leo I Gordon, Jason R Westin, null null
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma. The New England journal of medicine (2021)
Mathilde R W de Jong, Myra Langendonk, Bart Reitsma, Pien Herbers, Monique Lodewijk, Marcel Nijland, Anke van den Berg, Emanuele Ammatuna, Lydia Visser, Tom van Meerten
WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma. Therapeutic advances in hematology 11 (2020)
Mathilde Rikje Willemijn de Jong, Myra Langendonk, Bart Reitsma, Marcel Nijland, Anke van den Berg, Emanuele Ammatuna, Lydia Visser, Tom van Meerten
Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma. International journal of molecular sciences 20 (23) (2019)
Patrick J Engelberts, Marleen Voorhorst, Janine Schuurman, Tom van Meerten, Joost M Bakker, Tom Vink, Wendy J M Mackus, Esther C W Breij, Stefanie Derer, Thomas Valerius, Jan G J van de Winkel, Paul W H I Parren, Frank J Beurskens
Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells. Journal of immunology (Baltimore, Md. : 1950) 197 (12) (2016)